维普中文期刊产品整合服务
9篇 您的检索式:作者名="Herzig KA"
    题名 作者 年代 出处 被引量
1Risk factors for carotid plaque progression after optimising the risk factor treatment: substudy results of the Atherosclerotic Plaque Characteristics Associated with a Progression Rate of the Plaque and a Risk of Stroke in Patients with the carotid Bifurcation Plaque Study (ANTIQUE)显示文摘Background and aim Carotid plaque progression contributes to increasing stroke risk.The study aims to identify factors influencing carotid plaque thickness progression after changing the preventive treatment to the‘treating arteries instead of risk factors’strategy,that is,change in treatment depending on the progression of atherosclerosis.Methods The study participants who completed sonographic controls over the course of 3 years were enrolled to the analysis.Duplex sonography of cervical arteries was performed in 6-month intervals with measurement of carotid plaque thickness.Plaque thickness measurement error(σ)was set as 3 SD.Only evidently stable and progressive plaques(defined as plaque thickness difference between initial and final measurements of˂σand>2σ,respectively)were included to analysis.Univariate and multivariate logistic regression analysis was performed to identify factors influencing plaque progression.Results A total of 1391 patients(466 males,age 67.2±9.2 years)were enrolled in the study.Progressive plaque in at least one carotid artery was detected in 255(18.3%)patients.Older age,male sex,greater plaque thickness,coronary heart disease,vascular surgery/stenting history and smoking were more frequently present in patients with progressive plaque(p˂0.05 in all cases).Multivariate logistic regression analysis identified only the plaque thickness(OR 1.850 for left side,95%CI 1.398 to 2.449;and OR 1.376 for right side,95%CI 1.070 to 1.770)as an independent factor influencing plaque progression.Conclusion Carotid plaque thickness corresponding to stenosis severity is the only independent risk factor for plaque thickness progression after optimising the prevention treatment.David Školoudik Petra Kešnerova Tomaš Hrbač David Netuka Jaroslav Vomačka Kateřina Langova Roman Herzig Tomaš Belšan 2022Stroke & Vascular Neurology2022,7,2:3
2A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients显示文摘Johnson DW Herzig KA Gissane R 2001Nephrol Dial Transplant2001,16,9:1
3A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients 显示文摘Johnson DW Herzig KA Gissane R 2001Nephrol Dial Transplant2001,16,9:1
4Oral versus intravenous iron supplementation in peritoneal dialysis patients显示文摘Johnson DW Herzig KA Gissane R 0,,3:1
5Oral versus intravenous iron supplementation in peritoneal dialysis patients显示文摘Johnson DW Herzig KA Gissane R 2001Petit Dial Int2001,21,3:1
6Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients显示文摘Herzig KA Purdie DM Chang W 2001J Am Soe Nephrol2001,12,4:1
7Effects of MPEP on expression of food, MDMA or amphetamine conditioned place preference in rats显示文摘Herzig V Capuani EM Kovar KA 2005Addict BioI2005,10,:1
8A single-centre experience of post-renal transplant lymphoproliferative disorder显示文摘Herzig KA Juffs HG Norris D 2003Transpl Int2003,16,7:1
9Effects of MPEP on expression of food-,MDMA-or amphetamine-conditioned place preference in rats显示文摘Herzig V Capuani EM Kovar KA 2005Addict Biol2005,10,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费